You may not know it, but November 8, 2023, marked a significant end date for the U.S. Patent and Trademark Office (USPTO).
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
Under U.S. law, patent marking is optional. One may ask, well, then why do it? The short answer; damages.
If your client’s invention is focused on, or relates to, achieving net-zero greenhouse gas emissions, the U.S. Patent and Trademark Office (USPTO) is in your corner, now more than ever. On June 6, 2023, the USPTO expanded the eligibility requirements of the Climate Change Mitigation Pilot Program to apply to a greater breadth of technologies.
In April 2023, the U.S. Patent & Trademark Office (USPTO) announced proposed changes to some of the fees that it charges with respect to patent applications, design patents and America Invents Act trials.
In the U.S., patents will soon be granted electronically starting April 18, 2023.
As of December 29, 2022, the USPTO reduced the fees relating to patents matters for small and micro-entities.
For the last decade, the After Final Consideration Pilot Program 2.0 (AFCP) has been an option for U.S. patent applicants to use when their applications receive a Final Office Action.
- EventNavigating Tough Personnel Matters: Lessons, Strategies and Real-World Insights
- EventHealth Law Webinar – Health Care Transactions Under Scrutiny: New State Notice Laws, Corporate Practice of Medicine Developments and Emerging Risks
- Firm NewsLynn Linné Receives MSBA Distinguished Service Award; Jennifer Pusch and Dylan Saul Elected to Tax Section Leadership
- Firm NewsFredrikson Earns Pro Bono Award from The Advocates for Human Rights